Targeted Nanotherapeutics Encapsulating Liver X Receptor Agonist GW3965 Enhance Antiatherogenic Effects without Adverse Effects on Hepatic Lipid Metabolism in Ldlr-/- Mice.
Yu M, Amengual J, Menon A, Kamaly N, Zhou F, Xu X, Saw PE, Lee SJ, Si K, Ortega CA, Choi WI, Lee IH, Bdour Y, Shi J, Mahmoudi M, Jon S, Fisher EA, Farokhzad OC.
Yu M, et al. Among authors: zhou f.
Adv Healthc Mater. 2017 Oct;6(20):10.1002/adhm.201700313. doi: 10.1002/adhm.201700313. Epub 2017 Jul 21.
Adv Healthc Mater. 2017.
PMID: 28730752
Free PMC article.